{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/23981"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/23981","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Producing Medical Radioisotopes with CANDU Nuclear Reactors","abstract":"In the field of nuclear medicine, radioisotopes are used for applications such as diagnostic imag- ing, treatment, and equipment sterilization. The most commonly used radioisotope in medicine is technetium-99m (Tc-99m). It is used in 80% of all nuclear medicine procedures. Its parent isotope is molybdenum-99 (Mo-99). NRU, which is now closed, formerly produced 40% of the worlds demand for Mo-99. The production capacity of this reactor has been supplemented by a network of cyclotrons and a modified research reactor. This study aims to provide an alternative means of production for Mo-99, as well as other radioisotopes by modifying the center pin of a standard 37-element bundle of a CANDU reactor. The neutron transport code DRAGON, and the neutron diffusion code DONJON were used to model a CANDU-9 reactor. The lowest, median, and highest power channels were chosen as candi- dates for the modified bundles. It was found that the reactor parameters were altered by a negligible amount when any one channel was used to house the modified bundles. Significant quantities of the radioisotope lutetium-177 as well as the generating isotopes of the alpha-emitting radioisotopes lead- 212/bismuth-212, and radium-223 were produced. However, only minute amounts of molybdenum-99, and the generating isotope of bismuth-213 were produced.","abstract_html":"In the field of nuclear medicine, radioisotopes are used for applications such as diagnostic imag- ing, treatment, and equipment sterilization. The most commonly used radioisotope in medicine is technetium-99m (Tc-99m). It is used in 80% of all nuclear medicine procedures. Its parent isotope is molybdenum-99 (Mo-99). NRU, which is now closed, formerly produced 40% of the worlds demand for Mo-99. The production capacity of this reactor has been supplemented by a network of cyclotrons and a modified research reactor. This study aims to provide an alternative means of production for Mo-99, as well as other radioisotopes by modifying the center pin of a standard 37-element bundle of a CANDU reactor. The neutron transport code DRAGON, and the neutron diffusion code DONJON were used to model a CANDU-9 reactor. The lowest, median, and highest power channels were chosen as candi- dates for the modified bundles. It was found that the reactor parameters were altered by a negligible amount when any one channel was used to house the modified bundles. Significant quantities of the radioisotope lutetium-177 as well as the generating isotopes of the alpha-emitting radioisotopes lead- 212/bismuth-212, and radium-223 were produced. However, only minute amounts of molybdenum-99, and the generating isotope of bismuth-213 were produced.","abstract_has_math":false,"creators":["Sutherland, Zachary"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Engineering Physics and Nuclear Engineering","school":null,"contributors":[],"advisors":["Novog, David"],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-11-18T19:31:35Z","subjects":["lutetium-177","molybdenum-99","radium-223","lead-212","bismuth-212","Mo-99","radioisotope","CANDU","DRAGON","DONJON","NJOY"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/10178"],"render_values":[{"text":"https://doi.org/10.71548/10178","href":"https://doi.org/10.71548/10178","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/23981","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/23981","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F23981","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Novog, David"]},{"key":"dc:contributor.department","label":"Department","values":["Engineering Physics and Nuclear Engineering"]},{"key":"dc:creator","label":"Author","values":["Sutherland, Zachary"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-03-08T20:55:43Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-03-08T20:55:43Z"]},{"key":"dc:date.issued","label":"Date","values":["2018"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["lutetium-177","molybdenum-99","radium-223","lead-212","bismuth-212","Mo-99","radioisotope","CANDU","DRAGON","DONJON","NJOY"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/23981","https://doi.org/10.71548/10178"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["In the field of nuclear medicine, radioisotopes are used for applications such as diagnostic imag- ing, treatment, and equipment sterilization. The most commonly used radioisotope in medicine is technetium-99m (Tc-99m). It is used in 80% of all nuclear medicine procedures. Its parent isotope is molybdenum-99 (Mo-99). NRU, which is now closed, formerly produced 40% of the worlds demand for Mo-99. The production capacity of this reactor has been supplemented by a network of cyclotrons and a modified research reactor. This study aims to provide an alternative means of production for Mo-99, as well as other radioisotopes by modifying the center pin of a standard 37-element bundle of a CANDU reactor. The neutron transport code DRAGON, and the neutron diffusion code DONJON were used to model a CANDU-9 reactor. The lowest, median, and highest power channels were chosen as candi- dates for the modified bundles. It was found that the reactor parameters were altered by a negligible amount when any one channel was used to house the modified bundles. Significant quantities of the radioisotope lutetium-177 as well as the generating isotopes of the alpha-emitting radioisotopes lead- 212/bismuth-212, and radium-223 were produced. However, only minute amounts of molybdenum-99, and the generating isotope of bismuth-213 were produced."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Applied Science (MASc)"]},{"key":"dc:title","label":"Title","values":["Producing Medical Radioisotopes with CANDU Nuclear Reactors"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Novog, David"],"dc:contributor.department":["Engineering Physics and Nuclear Engineering"],"dc:creator":["Sutherland, Zachary"],"dc:date.accessioned":["2019-03-08T20:55:43Z"],"dc:date.available":["2019-03-08T20:55:43Z"],"dc:date.issued":["2018"],"dc:description.abstract":["In the field of nuclear medicine, radioisotopes are used for applications such as diagnostic imag- ing, treatment, and equipment sterilization. The most commonly used radioisotope in medicine is technetium-99m (Tc-99m). It is used in 80% of all nuclear medicine procedures. Its parent isotope is molybdenum-99 (Mo-99). NRU, which is now closed, formerly produced 40% of the worlds demand for Mo-99. The production capacity of this reactor has been supplemented by a network of cyclotrons and a modified research reactor. This study aims to provide an alternative means of production for Mo-99, as well as other radioisotopes by modifying the center pin of a standard 37-element bundle of a CANDU reactor. The neutron transport code DRAGON, and the neutron diffusion code DONJON were used to model a CANDU-9 reactor. The lowest, median, and highest power channels were chosen as candi- dates for the modified bundles. It was found that the reactor parameters were altered by a negligible amount when any one channel was used to house the modified bundles. Significant quantities of the radioisotope lutetium-177 as well as the generating isotopes of the alpha-emitting radioisotopes lead- 212/bismuth-212, and radium-223 were produced. However, only minute amounts of molybdenum-99, and the generating isotope of bismuth-213 were produced."],"dc:description.degree":["Master of Applied Science (MASc)"],"dc:identifier.uri":["http://hdl.handle.net/11375/23981","https://doi.org/10.71548/10178"],"dc:language.iso":["en"],"dc:subject":["lutetium-177","molybdenum-99","radium-223","lead-212","bismuth-212","Mo-99","radioisotope","CANDU","DRAGON","DONJON","NJOY"],"dc:title":["Producing Medical Radioisotopes with CANDU Nuclear Reactors"],"dc:type":["Thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:31:35Z"}